A team of Swedish researchers has discovered that a drug traditionally meant for type 2 diabetes shows promise in keeping prostate cancer at bay.

Prostate cancer is the fourth most common cancer among men in India. Often symptomless in its early stages, it is highly ...

Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...

Here’s what you should know about PSA screening, why medical guidelines vary and why individualized approaches are essential ...

For more than 30 years, Suzy Lawrence has been a steadfast advocate for people impacted by cancer. Her journey with the ...

Henry Butler is a prostate cancer survivor going on five years. He opens up about what recovery was like and how this journey ...

Black health experts discuss how clinical trials can help mitigate Black disease and reduce cancer to a chronic illness.

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.

Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...

New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...

HBCU Legends dives into the pulse of HBCU sports—covering everything from breaking health news and prostate cancer awareness ...